Search

Displaying results 1081 - 1090 of 9667 in total
  1. Drug

    Phendimetrazine

    go.drugbank.com/drugs/DB01579
    ApprovedIllicit

    Phendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances and in the US since 1970.

    Products: Fendique ER, Phendimetrazine Tartrate ER
  2. Drug

    Tazobactam

    go.drugbank.com/drugs/DB01606
    ApprovedInvestigational

    It is combined with [Piperacillin] and [Ceftolozane] for the treatment of a variety of bacterial infections. … Piperacillin-tazobactam was initially approved by the FDA in 1994, and ceftolozane-tazobactam was approved by the FDA in 2014[FDA label], providing wider antibacterial coverage for gram-negative infections

    Mixtures: Tazocin Pws IV 2g Piperacillin-.25g Tazobac., Tazocin Pws IV 4g Piperacillin-.5g Tazobac.Products: TAZOCIN EF
  3. Drug

    Potassium Iodide

    go.drugbank.com/drugs/DB06715
    ApprovedInvestigational

    Saturated solution of Potassium Iodide (SSKI) is used pharmaceutically for emergency use in patients experiencing acute symptoms of severe hyperthyroidism (also known as thyroid storm or thyrotoxic crisis

    Mixtures: Vitamines Et Mineraux, Trace Minerals Et/and B12 TabProducts: Thyroblock Tab 130mg
  4. Drug

    Melatonin

    go.drugbank.com/drugs/DB01065
    ApprovedInvestigationalNutraceuticalVet approved

    Reduced melatonin production has also been proposed as a likely factor in the significantly higher cancer rates in night workers.

    International brands: Mela-TProducts: CIRCADIN ® 2MG, PROLONGED RELEASE TABLETS 2MG
  5. Drug

    Calcium ascorbate

    go.drugbank.com/drugs/DB14483
    ApprovedNutraceutical

    Mixtures: Supplements De Vitamines Et Mineraux, Calcium Ascorbate Ctr Srt 450mgProducts: Chewable Vitamin C Tab 250mg
  6. Drug

    Denosumab

    go.drugbank.com/drugs/DB06643
    ApprovedInvestigational

    [A263066] An Denosumab biosimilar, Jubbonti, was approved for Health Canada in February 2024.[L52083]. … [A263066] Denosumab was approved by the FDA approved on June 2010 for the treatment of osteoporosis in postmenopausal women.

    Products: Prolia Solution for Injection 60mg Pre-filled Syringe, Prolia Solution for Injection 60mg/ml Pre-filled Syringe
  7. Drug

    Panitumumab

    go.drugbank.com/drugs/DB01269
    ApprovedInvestigational

    Panitumumab was granted FDA approval on 27 September 2006.[L17663]

    Products: Vectibix 100mg Concentrate for Solution for Infusion
  8. Drug

    Levocetirizine

    go.drugbank.com/drugs/DB06282
    ApprovedInvestigational

    [A181748,A181790,L7694] It is the R enantiomer of [cetirizine].[L7694] Levocetirizine has greater affinity for the histamine H<sub>1</sub> receptor than cetirizine. … [L7694] Levocetirizine was granted FDA approval in 1995.[L7694]

    Mixtures: PAX FORTE, PAX FORTE®Products: LEVOCETIRIZIN - CT 5MG FTA, LEVOCETIRIZINA EG
  9. Drug

    PA-1050040

    go.drugbank.com/drugs/DB06039
    Experimental

    It inhibits virus replication by the same mechanism of action as BVM.

  10. Drug

    Fingolimod

    go.drugbank.com/drugs/DB08868
    ApprovedInvestigational

    It was developed by Novartis and initially approved by the FDA in 2010.[L12651] Fingolimod was also studied for the treatment of COVID-19, the disease caused by infection with the SARS-CoV-2 virus.

    Products: PMS-fingolimod, FINGOLIMOD EG